While Bioceres Crop Solutions (NASDAQ:BIOX) shareholders have made 132% in 3 years, increasing losses might now be front of mind as stock sheds 8.2% this week

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But if you buy shares in a really great company, you can more than double your money. For example, the Bioceres Crop Solutions Corp. (NASDAQ:BIOX) share price has soared 132% in the last three years. Most would be happy with that. On the other hand, the stock price has retraced 8.2% in the last week. However, this might be related to the overall market decline of 5.3% in a week.

Although Bioceres Crop Solutions has shed US$63m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

View our latest analysis for Bioceres Crop Solutions

Because Bioceres Crop Solutions made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

In the last 3 years Bioceres Crop Solutions saw its revenue grow at 34% per year. That's much better than most loss-making companies. Meanwhile, the share price performance has been pretty solid at 32% compound over three years. This suggests the market has recognized the progress the business has made, at least to a significant degree. Nonetheless, we'd say Bioceres Crop Solutions is still worth investigating - successful businesses can often keep growing for long periods.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
NasdaqGS:BIOX Earnings and Revenue Growth March 14th 2023

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

Advertisement

A Different Perspective

Bioceres Crop Solutions shareholders are down 23% for the year, falling short of the market return. Meanwhile, the broader market slid about 7.3%, likely weighing on the stock. Fortunately the longer term story is brighter, with total returns averaging about 32% per year over three years. Sometimes when a good quality long term winner has a weak period, it's turns out to be an opportunity, but you really need to be sure that the quality is there. It's always interesting to track share price performance over the longer term. But to understand Bioceres Crop Solutions better, we need to consider many other factors. For instance, we've identified 1 warning sign for Bioceres Crop Solutions that you should be aware of.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Valuation is complex, but we're here to simplify it.

Discover if Bioceres Crop Solutions might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:BIOX

Bioceres Crop Solutions

Develops and commercializes crop productivity solutions.

Good value with mediocre balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.675.1% undervalued
13 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.2535.6% undervalued
17 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2690.3% undervalued
7 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3410.2% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AL
alexbarongo
CRDB logo
alexbarongo on CRDB Bank ·

Critical analysis of CRDB Bank Tanzania (DSE: CRDB).CRDB Bank Tanzania — Critical Investment Analysis

Fair Value:TSh2.59k15.0% overvalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CG
BLCO logo
CG86 on Bausch + Lomb ·

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!

Fair Value:US$39.2357.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
9628 logo
AstrisCorporateAdvisory on SAN Holdings ·

Forging ahead with an ambitious growth plan

Fair Value:JP¥1.92k28.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3950.5% undervalued
45 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3133.1% undervalued
1357 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative